Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more
Cengild Medical Berhad (0243) - Total Assets
Latest total assets as of December 2025: RM218.07 Million MYR
Based on the latest financial reports, Cengild Medical Berhad (0243) holds total assets worth RM218.07 Million MYR as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cengild Medical Berhad - Total Assets Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cengild Medical Berhad - Asset Composition Analysis
Current Asset Composition (June 2025)
Cengild Medical Berhad's total assets of RM218.07 Million consist of 54.5% current assets and 45.5% non-current assets.
| Asset Category | Amount (MYR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 6.5% |
| Accounts Receivable | RM8.48 Million | 4.7% |
| Inventory | RM2.05 Million | 1.1% |
| Property, Plant & Equipment | RM0.00 | 0.0% |
| Intangible Assets | RM0.00 | 0.0% |
| Goodwill | RM0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cengild Medical Berhad's current assets represent 54.5% of total assets in 2025, an increase from 22.5% in 2020.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2025, down from 11.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 4.7% of total assets.
Cengild Medical Berhad Competitors by Total Assets
Key competitors of Cengild Medical Berhad based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
|
ALPHA
KLSE:0303
|
Malaysia | RM260.64 Million |
Cengild Medical Berhad - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Cengild Medical Berhad generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Cengild Medical Berhad generates $6.13 in net profit.
Cengild Medical Berhad - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.90 | 3.82 | 7.87 |
| Quick Ratio | 3.80 | 3.75 | 7.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RM57.71 Million | RM 80.13 Million | RM 82.49 Million |
Cengild Medical Berhad - Advanced Valuation Insights
This section examines the relationship between Cengild Medical Berhad's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.64 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 36.3% |
| Total Assets | RM180.49 Million |
| Market Capitalization | $12.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cengild Medical Berhad's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Cengild Medical Berhad's assets grew by 36.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cengild Medical Berhad (2020–2025)
The table below shows the annual total assets of Cengild Medical Berhad from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | RM180.49 Million | +36.28% |
| 2024-06-30 | RM132.44 Million | +0.54% |
| 2023-06-30 | RM131.73 Million | +10.19% |
| 2022-06-30 | RM119.54 Million | +160.01% |
| 2021-06-30 | RM45.98 Million | -2.37% |
| 2020-06-30 | RM47.09 Million | -- |